Skip to main content
Log in

An investigation into cytotoxic mechanisms in type I diabetes mellitus

  • Original Contributions
  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

T- and K-cell cytotoxic activity has been measured in groups of type I diabetic patients and comparable groups of healthy control subjects. The mean cytotoxic indices for T-cell activity were 0.72 for 13 type I diabetics and −2.38 for a control group. These values are not significantly different. K-cell cytotoxic activity was measured using both chicken red blood cells and Chang liver cells coated with appropriate xenogenic antibodies. Using the chicken red blood cell system the percentage specific chromium release was 55.3 for 17 type I diabetics and 50.0 for a control group. These values are not significantly different. Using the Chang liver cell system the percentage specific chromium release was 13.9 for 37 type I diabetics and 9.7 for a control group. This difference is statistically significant (p<0.05).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Asplin C. M., Hartog M., Goldie D. J.: Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin — Diabetologia14, 99, 1978.

    Article  PubMed  CAS  Google Scholar 

  2. Bottazzo G. F., Dean B. M., Gorsuch A. N., Cudworth A. G., Doniach D.: Complement-fixing islet-cell antibodies in type I diabetes: possible monitors of active beta-cell damage — Lanceti, 668, 1980.

    Article  Google Scholar 

  3. Bottazzo G. F., Mann J. I., Thorogood M., Baum J. D., Doniach D.: Autoimmunity in juvenile diabetics and their families — Brit. med. J.ii, 165, 1978.

    Article  Google Scholar 

  4. Berson S. A., Yalow R. S.: Quantative aspects of the reaction between insulin and insulin binding antibody — J. clin. Invest.38, 1996, 1959.

    Article  PubMed  CAS  Google Scholar 

  5. Berson S. A., Yalow R. S.: The present state of insulin antagonists in plasma — Diabetes13, 247, 1964.

    PubMed  CAS  Google Scholar 

  6. Bruni B., Gamba S., Regis G., Turco G. L.: Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment — Diabetologia14, 165, 1978.

    Article  PubMed  CAS  Google Scholar 

  7. Calder E. A., Irvine W. J., Davidson M. D., Wu F.: T-, B- and K-cells in autoimmune thyroid disease — Clin. exp. Immunol.25, 17, 1976.

    PubMed  CAS  Google Scholar 

  8. Cudworth A. G.: Diabetes — the possible aetiological role of viruses. In:Heath R. B. (Ed.): Virus diseases. Pitman Medical, Tunbridge Wells, 1979; p. 59.

  9. Cudworth A. G.: Type I diabetes mellitus — Diabetologia14, 281, 1978.

    Article  PubMed  CAS  Google Scholar 

  10. Di Mario U., Iavicoli M., Andreani D.: Circulating immune complexes in diabetes — Diabetologia19, 89, 1980.

    Article  PubMed  Google Scholar 

  11. Galama J. M. D., Vos A., Lucas C. J.: Lymphocyte-mediated cytotoxicity to autologous cells infected with measles virus. II. Specificity of the cytotoxic reaction and characterization of the effector cells involved — Cell. Immunol.48, 296, 1979.

    Article  PubMed  CAS  Google Scholar 

  12. Gepts W.: Pathological anatomy of the pancreas in juvenile diabetes mellitus — Diabetes14, 613, 1966.

    Google Scholar 

  13. Heding L. G., Larsson Y., Ludvigsson J.: The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin — Diabetologia19, 511, 1980.

    PubMed  CAS  Google Scholar 

  14. Huang S. W., MacLaren N. K.: Insulin dependent diabetes: a disease of autoaggression — Science192, 94, 1976.

    Article  Google Scholar 

  15. Iavicoli M., Di Mario U., Pozzilli P., Canalese J., Ventriglia L., Galfo C., Andreani D.: Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathy — Diabetes31, 7, 1982.

    Article  PubMed  CAS  Google Scholar 

  16. Junker K., Egeburg J., Kromann H.: An autopsy study of the islets of Langerhans in acute onset juvenile diabetes mellitus — Acta path. microbiol. scand.85 (A), 699, 1977.

    CAS  Google Scholar 

  17. Kohl S., Pickering L. K., Diluzio N. R.: Inhibition of human monocyte macrophage and lymphocyte cytotoxicity to herpes simplex-infected cells by glucan — J. immunol. Meth.29, 361, 1979.

    Article  CAS  Google Scholar 

  18. Koide Y., Takasugi M.: Determination of specificity in natural cell cytotoxicity by natural antibodies — J. nat. Cancer Inst.59, 1099, 1977.

    PubMed  CAS  Google Scholar 

  19. Kreth H. W., Wiegand G.: Cell mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells — J. Immunol.118, 296, 1977.

    PubMed  CAS  Google Scholar 

  20. Kurtz A. B., Matthews J. A., Mustaffa E. B., Daggett P. R., Nabarro J. D. N.: Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin — Diabetologia18, 147, 1980.

    Article  PubMed  CAS  Google Scholar 

  21. Lernmark Å., Freedman Z. R., Hoffman C., Rubenstein A. H., Steiner D. F., Jackson R. L., Winter R. J., Traisman H. S.: Islet cell surface antibodies in juvenile diabetes mellitus — New Engl. J. Med.299, 375, 1978.

    Article  PubMed  CAS  Google Scholar 

  22. Murray R. K., Suss R., Pitot H. C.: Isolation and characterization of cytoplasmic components of cancer cells — Meth. Cancer Res.ii, 244, 1967.

    Google Scholar 

  23. Nelson D. L., Bundy B. M., Pitchon N. E., Blaese R. M., Stroker W.: The effector cells in human peripheral blood mediating in mitogen-induced cellular toxicity and antibody-dependent cellular toxicity. — J. Immunol.117, 1472, 1976.

    PubMed  CAS  Google Scholar 

  24. Ortaldo J. R., MacDermott R. P., Bonnard G. D., Kind P. D., Heberman R. B.: Cytotoxicity from cultured cells: analysis of precursors involved in the generation of human cells mediating natural and antibody-dependent cell-mediated cytotoxicity — Cell. Immunol.48, 356, 1979.

    Article  PubMed  CAS  Google Scholar 

  25. Perlmann P., Perlmann P., Wigzell H.: Lymphocyte mediated cytotoxicityin vitro. Induction and inhibition by humoral antibody and nature of effector cells — Transplant. Rev.13, 91, 1972.

    PubMed  CAS  Google Scholar 

  26. Podleski N. K.: Cytotoxic lymphocytes in Hashimoto thyroiditis — Clin. exp. Immunol.11, 543, 1972.

    PubMed  CAS  Google Scholar 

  27. Pozzilli P., Sensi M., Gorsuch A., Bottazzo G. F., Cudworth A. G.: Evidence for raised K-cell levels in type I diabetes — Lancetii, 173, 1979.

    Article  Google Scholar 

  28. Rittenhouse H. G., Oxender D. L., Pek S., Ar D.: Complement-mediated cytotoxic effects on pancreatic islets with sera from diabetic patients — Diabetes29, 317, 1980.

    Article  PubMed  CAS  Google Scholar 

  29. Sensi M., Pozzilli P., Gorsuch A. N., Bottazzo G. F., Cudworth A. G.: Increased killer cell activity in insulin dependent (type 1) diabetes mellitus — Diabetologia20, 106, 1981.

    Article  PubMed  CAS  Google Scholar 

  30. Zeijlemaker W. P., van Oers M. H. J., de Goede R. E. Y., Schellekens P. Th: Cytotoxic activity of human lymphocytes: quantitative analysis of T-cell and K-cell cytotoxicity serial enzyme like kinetics — J. Immunol.119, 1507, 1977.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richens, E.R., Quilley, J. & Hartog, M. An investigation into cytotoxic mechanisms in type I diabetes mellitus. Acta diabet. lat 19, 329–337 (1982). https://doi.org/10.1007/BF02629255

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02629255

Key-words

Navigation